Abstract
In this and the companion work by my dear friend and colleague of 40 years, Per Wistrand, we shall dry to outline the various roles of carbonic anhydrase (CA) in the eye, giving briefly the chemistry and physiology of the reactions and the pharmacology of inhibiting sulfonamides. Much of this has been told before, and these references should be used for more detailed descriptions (Maren, 1987, 1995; Sugrue, 1996).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Bayer A, Maren TH, Erb C (1996) Inhibiteurs locaux de l’anhydrase carbonique dans le traitement du glaucome. J Fr Ophthalmol 19: 357–362
Becker B (1959) Carbonic anhydrase and the formation of aqueous humor. The Friedenwald memorial lecture. Am J Opthtalmol 47: 342–361
Conroy CW, Maren TH (1995) Effect of pH on drug disposition and corneal loading of the topical carbonic anhydrase inhibitor, MK-927. Exp Eye Res 61: 213–222
Krebs HA (1948) Inhibition of carbonic anhydrase by sulfonamides. Biochem J 43: 525–528
Mann T, Keilin D (1940) Sulfanilamide as a specific inhibitor of carbonic anhydrase. Nature 146: 164–165
Maren TH (1976) The rates of movement of Na+, Cl– and HCO –3 from plasma to posterior chamber: Effect of acetazolamide and relation to the treatment of glaucoma. Invest Ophthalmol 15: 356–364
Maren TH (1987) Carbonic anhydrase: General perspectives and advances in glaucoma research. Drug Devel Res 10: 255–276
Maren TH (1995) The development of topical carbonic anhydrase inhibitors. J Glaucoma 4: 49–62
Maren TH, Bar-Ilan A, Conroy CW, Brechue WF (1990) Chemical and pharmacological properties of MK-927, a sulfonamide carbonic anhydrase inhibitor that lowers intraocular pressure by the topical route. Exp Eye Res 50: 27–36
Roblin RO Jr, Clapp JW (1950) The preparation of heterocyclic sulfonamides. J Am Chem Soc 72: 4890–4892
Sugrue MF (1996) The preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor. J Ocular Pharmacol Therap 12: 363–376
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Basel AG
About this chapter
Cite this chapter
Maren, T.H. (2000). Carbonic anhydrase inhibition in ophthalmology: Aqueous humor secretion and the development of sulfonamide inhibitors. In: Chegwidden, W.R., Carter, N.D., Edwards, Y.H. (eds) The Carbonic Anhydrases. EXS 90, vol 90. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8446-4_21
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8446-4_21
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9570-5
Online ISBN: 978-3-0348-8446-4
eBook Packages: Springer Book Archive